Bellevue Group’s QuidelOrtho QDEL Stock Holding History

Bellevue Group’s Portfolio QDEL Stock Details QDEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-113,955	Closed	-$11.1M	–	221
2020 Q1	$11.1M	Sell	113,955 -223,573	-66%	-$18.1M	0.22%	80
2019 Q4	$25.3M	Buy	337,528 +177,512	+111%	+$11.5M	0.4%	56
2019 Q3	$9.82M	Sell	160,016 -108,454	-40%	-$6.53M	0.18%	87
2019 Q2	$15.9M	Buy	268,470 +44,890	+20%	+$2.69M	0.27%	63
2019 Q1	$14.6M	Buy	223,580 +98,580	+79%	+$5.96M	0.81%	41
2018 Q4	$6.1M	Buy	+125,000	New	+$7.46M	0.4%	60

Other funds holding QDEL

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bellevue Group's QDEL Position: Q2 2020 in Review

Bellevue Group sold out of QuidelOrtho (QDEL) in Q2 2020, closing a stake of 113,955 shares — an estimated $11.1M sold.

Bellevue Group first reported a position in QDEL in Q4 2018 and held it in 6 quarters. The position peaked at $25.3M in Q4 2019. 348 funds tracked by Wall St. Rank hold QDEL as of Q2 2020.

Bellevue Group reported no remaining QuidelOrtho position as of Q2 2020 after selling out during the quarter.
Bellevue Group sold 113,955 QuidelOrtho shares in Q2 2020, an estimated $11.1M.
Bellevue Group first reported a position in QuidelOrtho in Q4 2018 and held it in 6 quarters.
Bellevue Group's QuidelOrtho position peaked at $25.3M in Q4 2019.
348 funds tracked by Wall St. Rank held QuidelOrtho as of Q2 2020.

Based on Bellevue Group's 13F filing for Q2 2020, filed 13 Aug 2020.